• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Dutasteride 0.5mg daily has the highest probability of being the most efficacious treatment for male androgenetic alopecia

byKathleen Lau
February 10, 2022
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

RELATED REPORTS

The Scan by 2 Minute Medicine®: Kate Middleton’s Hair: Chemo Mysteries, MRI Screening: Is It Useful?, Biden’s COVID Amid Variant Surge, Avoiding Microplastics

#VisualAbstract: Ritlecitinib superior to placebo in the treatment of alopecia areata among teens and adults

Ritlecitinib superior to placebo in the treatment of alopecia areata among teens and adults

Tags: 5 alpha reductase inhibitorsalopeciaandrogenetic alopeciadutasteridefinasteridehair lossmale pattern hair lossminoxidil
Previous Post

#VisualAbstract: Effectiveness of sacubitril-valsartan in post-myocardial infarction management compared to ramipril

Next Post

Mobile stroke units associated with better outcomes for acute ischemic stroke management

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Kate Middleton’s Hair: Chemo Mysteries, MRI Screening: Is It Useful?, Biden’s COVID Amid Variant Surge, Avoiding Microplastics

July 23, 2024
#VisualAbstract: Ritlecitinib superior to placebo in the treatment of alopecia areata among teens and adults
StudyGraphics

#VisualAbstract: Ritlecitinib superior to placebo in the treatment of alopecia areata among teens and adults

January 29, 2024
Patient Basics: Alopecia Areata
Chronic Disease

Ritlecitinib superior to placebo in the treatment of alopecia areata among teens and adults

May 18, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Tennis Legends, Sausage Fingers, Alopecia Awareness Month and Starbucks Recalls!

September 20, 2022
Next Post
Quick Take: Efficacy of prehospital criteria in identifying trauma patients susceptible to undertriage

Mobile stroke units associated with better outcomes for acute ischemic stroke management

Rapid growth of medical artificial intelligence technology usage identified from insurance claims analysis, yet major barriers to widespread adoption remain

The spiritual history may improve the quality of the doctor-patient relationship

Patients with low back pain or pain at multiple sites at highest risk for chronic opioid use

Pain may be greater driver for suicidal behavior in youths and young adults than prescription opioids

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The American College of Physicians’ Recommendations for Effective Managed Care
  • Neighborhood exposure to cannabis stores increases cannabis-related emergency department visits
  • Advance care planning interventions increase electronic health record documentation
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.